Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2022-09-12 00:00:00 ET · period of report 2022-09-08 · accession 0001493152-22-025578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-12 | 2022-09-08 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $2.80 | +10.3K | 65.4K | +19% | +$28.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-09-08 | P | A | 10,308 | $2.80 | 65,374 | D | — | — |